Determination of designer doping agent - 2-ethylamino-1-phenylbutane - in dietary supplements and excretion study following single oral supplement dose

- A new designer stimulant, 2-ethylamino-1-phenylbutane (EAPB) is investigated.
- Excretion study following single oral administration of supplements containing EAPB.
- Validation of the GC-MS methods for determination of EAPB in urine and supplement.
- Detection and determination of EAPB in fourteen investigated dietary supplements.
- The case of EAPB detection in the anti-doping control is presented.